Pharmaceutical Technology

OCTOBER 28, 2022

Since most biologics and biosimilars are large molecules, they may prove challenging to develop and manufacture on the large scale. However, the adoption of automation in the lab setting can set the stage for a pilot phase to drive optimisation and efficiency into a new era of drug development and manufacturing.

Biosimilars 52

Biosimilars Vaccines Drug Development Documentation 52

Pharma Marketing Network

JULY 21, 2023

Some relevant keywords to include are: pharmaceutical, drug development, clinical trials, medical research, and healthcare. Joining relevant groups is a great way to connect with other professionals in your field and to participate in discussions about the latest trends and developments in the industry.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind. Since the FDA approved AstraZeneca’s monoclonal antibody therapy Synagis (palivizumab) 25 years ago, drug development successes for RSV have been few and far between.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Quality Matters

NOVEMBER 10, 2022

and other countries to help guard against potential drug shortages and medicines supply chain disruptions. Implementing such innovation will take time, however, in part because of obstacles that some drug developers and manufacturers can face when considering whether to adopt PCM.

Drug Development 52

Drug Development 52

Pharma Marketing Network

NOVEMBER 15, 2024

From discussions on branded drug developments to sessions hosted by major players like Pfizer and Novartis , there’s always something to learn. Whether it’s with academic institutions or industry colleagues, collaborating on white papers or case studies can have long-lasting benefits.

Drug Development 40

Drug Development 40

European Pharmaceutical Review

DECEMBER 21, 2022

He is currently group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH. His research activities led to the foundation of five startup companies active in disciplines ranging from drug development to industrial biotech within the past 15 years. in South San Francisco, CA, USA.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Putting Patients First Blog

APRIL 14, 2023

Driven by the work of the Food and Drug Administration on patient-focused drug development (PFDD), many companies in the biopharmaceutical community have devoted significant resources to better understand patient populations and are working to bring to market products that best suit their needs. Sincerely, Randall L.

Drug Pricing 40

Drug Pricing Drug Development Documentation Communication 40

Putting Patients First Blog

JUNE 30, 2023

No mention was provided in the proposed changes nor the white paper on Advancing Health Technology Assessment Methods that Support Health Equity of clinical trial participants with differential abilities. have robust suggestions on increasing diversity in clinical trials for sponsors and drug developers.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

Pharmaceutical Technology

FEBRUARY 23, 2023

As formulators, we are often able to directly impact the amount of drug absorbed through formulation optimization and improve exposure. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited. S54 – S61 (2001).

Drug Development 98

Drug Development Compounding Dosage Packaging 98

Pharmaceutical Technology

DECEMBER 7, 2022

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. The post Alzheimer’s disease biomarkers galvanise rocky drug development space appeared first on Pharmaceutical Technology.

Drug Development 105

Drug Development Communication Immunity Immunization 105

Pharmaceutical Technology

DECEMBER 7, 2022

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. The post Alzheimer’s disease biomarkers galvanize rocky drug development space appeared first on Pharmaceutical Technology.

Drug Development 98

Drug Development Communication Immunity Immunization 98

Fuld & Company Blog

MARCH 12, 2025

A list of the top healthcare and life sciences conferences in the US and Europe Key event details, including dates, locations, and registration links Coverage of specialist fields: Cardiology Immunology Oncology Renal Whether you’re a healthcare professional, researcher, or industry leader, this directory is your go-to guide for planning your (..)

Documentation 52

Documentation Drug Development 52

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

MAY 3, 2023

In a white paper titled “Access Denied: Why New Generics Are Not Reaching America’s Seniors,” the AAM analysis indicates that patients may wait up to three years for first generic competitors to costly brands. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines.

Generic Medicine 98

Generic Medicine Drug Development Communication Diabetes 98

Pharmaceutical Technology

DECEMBER 9, 2022

. <p>Early Access Programs (EAPs) are a pathway for pharmaceutical companies to provide innovative drugs to patients living with serious conditions. These treatments may still be in development or already have approval somewhere in the world. </p> </p> By Tanner Pharma Group.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

JANUARY 22, 2023

Nicklas Westerholm, the CEO and president of orphan drug developer Egetis Therapeutics, says disease awareness amongst paediatric neurologists and endocrinologists is low for MCT8 deficiency. The mutation leads to disordered thyroid hormone transport, which causes patients to experience intellectual and motor disabilities.

Communication 126

Communication Dosage Drug Development 126

Pharmaceutical Technology

MARCH 6, 2023

Teijin Pharma is also eligible for up to $200m in potential development and commercial milestone payments along with further additional sales milestones as well as tiered annual net sales royalties. It stated that the candidate is believed to impact the pathogenesis of several kidney diseases and works in a genetically validated pathway.

Compounding 105

Compounding Communication Drug Development 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

DECEMBER 13, 2022

Prominent SaaS systems were a huge inspiration, McVeigh says, but the technical challenge presented by the drug development world came with different demands. At the same time, Suvoda has built a large API surface on top of the platform architecture that will simplify integrations with other eClinical systems.

Communication 104

Communication Drug Development 104

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98

Pharmaceutical Technology

DECEMBER 8, 2022

Instead of starting with ‘what equipment do we have’, we’re really starting with our end goal by considering what is required by the drug developers,” explains Lenaerts. This is something that sets Datwyler’s approach apart from its competitors.

Packaging 98

Packaging Vaccines Communication Drug Development 98

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. Teddy Lab has been a trusted partner for many years and mirrors our commitment to high-quality, patient-centric solutions.

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Pharmaceutical Technology

MARCH 24, 2023

In light of World TB day on March 24, the field hopes to overcome some major barriers to the drug development landscape. Unfortunately, lack of funding and resources remain an obstacle within the TB field for developing new vaccines. The BCG vaccine is a live-attenuated virus vaccine.

Vaccines 64

Vaccines Health and Personal Care Stores Immunity Immunization 64

Pharmaceutical Technology

MARCH 15, 2023

According to GlobalData’s Pharma Intelligence Center Deals Database, figure 1 shows the parent holding company SVB Financial Group and its subsidiaries were involved in more than $1.4bn in total venture financing raised from 2010 to 2022 for drug development. Free Report How is the Biopharmaceutical industry evolving?

Drug Development 59

Drug Development Communication 59

Pharmaceutical Technology

FEBRUARY 20, 2023

On the other hand, a lack of diversity in clinical trial populations, particularly when the disease population is significantly underrepresented, greatly diminishes the quality of data obtained for drug safety and efficacy profiles. This may sound obvious, but it is still a major hurdle in drug development.

Vaccines 52

Vaccines Communication Immunity Immunization 52

Pharmaceutical Technology

MARCH 23, 2023

Scientific research and a better understanding of the condition is driving new developments in medications. The condition’s symptoms are not homogeneous, and that makes drug development complicated,” Javier Szwarcberg, CEO of Spruce Biosciences, a rare disease company researching endocrine disorders, says.

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

FEBRUARY 21, 2023

Versatility Finding a versatile R&D tablet press is key for flexible drug development. This is where compaction simulation really shines, believes Ingrid Coyle, MEDELPHARM’s director of corporate business development and communication. Every step has been thought of from a user experience perspective.”

Communication 52

Communication Drug Development Dosage 52

Pharmaceutical Technology

MARCH 9, 2023

Under the partnership, the Centre for Drug Development of Cancer Research UK will appoint the chief clinical and scientific investigators. The potential first-in-class antibody UCB6114 targets a glycoprotein secreted by the tumour stroma, gremlin-1.

Communication 52

Communication Immunity Immunization Drug Development 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT.

Drug Development 52

Drug Development Packaging Communication 52

Pharmaceutical Technology

JANUARY 26, 2023

Free Whitepaper Precision Medicine: Streamlining Treatments and Drug Development Precision medicine has the potential to radically change the way health services are delivered, combining medical expertise with the latest technology to provide bespoke treatments for individual patients. It is very promising what the future will bring.”

Communication 52

Communication Diabetes Drug Development 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Biocytogen Pharmaceuticals president and CEO Dr Yuelei Shen said: “Chipscreen Biosciences and Chipscreen NewWay have extensive experience in clinical drug development and commercialisation. It also activated tumour-infiltrating DCs and T cells in vivo pharmacodynamic studies.

Immunity 52

Immunity Immunization Communication Drug Development 52

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. This was higher than the number of approvals in 2019 and 2020.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 28, 2022

To learn more about the development and partnership opportunities for businesses within Scotland’s health sector, download the document on this page. Precision Medicine: Streamlining Treatments and Drug Development. Free Whitepaper.

Hospitals 52

Hospitals Packaging Medical Schools Documentation 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Orphan drug development is expanding Change is happening. 1983 was a pivotal year for the rare disease community, with the US Food and Drug Administration’s introduction of the Orphan Drug Act. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52